scholarly article | Q13442814 |
P356 | DOI | 10.3109/00207459408987238 |
P698 | PubMed publication ID | 7928104 |
P2093 | author name string | Sandyk R | |
Iacono RP | |||
P2860 | cites work | Deficient learning and memory in early and middle phases of multiple sclerosis | Q33619519 |
Neuropsychological syndromes in presenile dementia due to cerebral atrophy | Q33621936 | ||
Sleep induced by the administration of melatonin (5-methoxy-N-acetyltryptamine) to the hypothalamus in unrestrained cats | Q51271704 | ||
A comparison of dementia in Alzheimer's disease and multiple sclerosis. | Q52066615 | ||
On drawing impairment in Alzheimer's disease. | Q52102002 | ||
Melatonin: Effects on brain and behavior | Q52105997 | ||
Intellectual impairment in multiple sclerosis and its relation to functional abilities | Q52106712 | ||
Memory disturbance in chronic progressive multiple sclerosis. | Q52210743 | ||
Cognitive functioning in multiple sclerosis. | Q52265827 | ||
Asymmetrical cognitive deterioration in demented and Parkinson patients. | Q52291302 | ||
Effects of an Earth-strength magnetic field on electrical activity of pineal cells | Q59063163 | ||
Reversible chronic cerebellar ataxia after phenytoin intoxication: possible role of cerebellum in cognitive thought | Q34199212 | ||
Subcortical neglect | Q34281363 | ||
Suppression of Human Growth Hormone Secretion by Melatonin and Cyproheptadine | Q34463534 | ||
Role of the cerebellum in complex human behavior | Q34541328 | ||
Cerebellar contributions to the Papez circuit | Q34746184 | ||
Nocturnal Plasma Melatonin and Alpha-Melanocyte Stimulating Hormone Levels During Exacerbation of Multiple Sclerosis | Q35223138 | ||
Effects of melatonin on sleep and neurochemistry in the rat | Q36123922 | ||
Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases | Q36994104 | ||
Monoamine metabolites in cerebrospinal fluid in multiple sclerosis | Q37054783 | ||
Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis | Q37100307 | ||
Emotional and cognitive correlates of multiple sclerosis. | Q37848563 | ||
Cognitive loss in multiple sclerosis. Case reports and review of the literature | Q38602567 | ||
The distribution of plaques in the cerebrum in multiple sclerosis | Q39412145 | ||
Geomagnetic field detection in rodents | Q39627574 | ||
Neuropsychology of multiple sclerosis: a critical review | Q39801476 | ||
Neuropeptide MSH/ACTH 4–10 enhances attention in the mentally retarded | Q40043520 | ||
The opiomelanotropinergic neuronal and endocrine systems | Q40131246 | ||
Effects of MSH/ACTH 4–10 on memory, attention and endogenous hormone levels in women☆ | Q40142341 | ||
Specific Binding of Melatonin in Bovine Brain* | Q40237755 | ||
Melatonin receptors in brain | Q40237903 | ||
Diurnal changes in melatonin binding sites of hamster and rat brains. Correlation with neuroendocrine responsiveness to melatonin | Q40287154 | ||
A cortical network for directed attention and unilateral neglect | Q40321279 | ||
The role of melatonin and serotonin in aging | Q41345262 | ||
Brain autoradiographic study in the golden hamster after intracarotid injection of [14C]melatonin | Q44243139 | ||
Dissociated neglect behavior following sequential strokes in the right hemisphere | Q44286522 | ||
Anatomical features and physiological properties of central serotonin neurons | Q44393226 | ||
Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis | Q44885412 | ||
Influence of neonatal injections of alpha-MSH on learning, memory and attention in rats | Q45081095 | ||
Cerebral multiple sclerosis | Q45238327 | ||
A controlled neuropsychological comparison of Huntington's disease and multiple sclerosis | Q45297347 | ||
5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases | Q45303241 | ||
MSH Activity in Plasma and Pituitaries of Rats After Various Treatments | Q47804080 | ||
Melatonin Receptor Sites in the Syrian Hamster Brain and Pituitary. Localization and Characterization Using [|]lodomelatonin*. | Q47838524 | ||
Ouabain-induced seizures in rats: modification by melatonin and melanocyte-stimulating hormone | Q47943774 | ||
Static magnetic fields decrease nocturnal pineal cAMP in the rat. | Q48088601 | ||
Hypoarousal in patients with the neglect syndrome and emotional indifference | Q48208286 | ||
Magnetic fields abolish nychthemeral rhythmicity of responses of Purkinje cells to the pineal hormone melatonin in the pigeon's cerebellum | Q48265067 | ||
Differential localization of N-acetylated indolealkylamines in CNS and the Harderian gland using immunohistology | Q48343189 | ||
Growth Hormone Responses to Melatonin in Man | Q48547163 | ||
Effects of melatonin on human mood and performance | Q48590556 | ||
Growth Hormone Regulation by Melatonin and Serotonin | Q48642831 | ||
Interactions between pineal, hypothalamus, and pituitary involving melatonin, MSH release-inhibiting factor and MSH. | Q48716113 | ||
Right thalamic injury, impaired visuospatial perception, and alexia | Q48968520 | ||
Psycho-physiologic correlates of MSH activity in man | Q51116122 | ||
P433 | issue | 1-4 | |
P921 | main subject | multiple sclerosis | Q8277 |
P1104 | number of pages | 13 | |
P304 | page(s) | 177-189 | |
P577 | publication date | 1994-01-01 | |
P1433 | published in | International Journal of Neuroscience | Q6051511 |
P1476 | title | Multiple sclerosis: improvement of visuoperceptive functions by picoTesla range magnetic fields | |
P478 | volume | 74 |
Q36681597 | Chronic relapsing multiple sclerosis: a case of rapid recovery by application of weak electromagnetic fields |
Q38961506 | Extremely low frequency electromagnetic fields stimulation modulates autoimmunity and immune responses: a possible immuno-modulatory therapeutic effect in neurodegenerative diseases. |
Q52000784 | Immediate recovery of cognitive functions and resolution of fatigue by treatment with weak electromagnetic fields in a patient with multiple sclerosis. |
Q52056215 | Improvement in word-fluency performance in patients with multiple sclerosis by electromagnetic fields. |
Q41069606 | Long term beneficial effects of weak electromagnetic fields in multiple sclerosis |
Q41163507 | Premenstrual exacerbation of symptoms in multiple sclerosis is attenuated by treatment with weak electromagnetic fields |
Q41069613 | Reversal of alexia in multiple sclerosis by weak electromagnetic fields |
Q48498380 | Treatment with electromagnetic fields improves dual-task performance (talking while walking) in multiple sclerosis |
Search more.